» Articles » PMID: 30778380

Epstein-Barr Virus-Associated γδ T-Cell Lymphoproliferative Disorder Associated With Hypomorphic Mutation

Abstract

Chronic active Epstein-Barr virus (EBV) infection (CAEBV) is an EBV-associated lymphoproliferative disease characterized by repeated or sustainable infectious mononucleosis (IM)-like symptoms. EBV is usually detected in B cells in patients who have IM or Burkitt's lymphoma and even in patients with X-linked lymphoproliferative syndrome, which is confirmed to have vulnerability to EBV infection. In contrast, EBV infects T cells (CD4 T, CD8 T, and γδT) or NK cells mono- or oligoclonally in CAEBV patients. It is known that the CAEBV phenotypes differ depending on which cells are infected with EBV. CAEBV is postulated to be associated with a genetic immunological abnormality, although its cause remains undefined. Here we describe a case of EBV-related γδT-cell proliferation with underlying hypomorphic mutation. The immunological phenotype consisted of γδT-cell proliferation in the peripheral blood. A presence of EBV-infected B cells and γδT cells mimicked γδT-cell-type CAEBV. Although the patient had normal expression of CD132 (common γ chain), the phosphorylation of STAT was partially defective, indicating impaired activation of the downstream signal of the JAK/STAT pathway. Although the patient was not diagnosed as having CAEBV, this observation shows that CAEBV might be associated with immunological abnormality.

Citing Articles

Clinical significance of anti-Epstein-Barr virus antibodies in systemic chronic active Epstein-Barr virus disease.

Nishio M, Saito M, Yoshimori M, Kumaki Y, Ohashi A, Susaki E Front Microbiol. 2024; 14:1320292.

PMID: 38260896 PMC: 10800478. DOI: 10.3389/fmicb.2023.1320292.


Potential molecular mechanisms of chronic fatigue in long haul COVID and other viral diseases.

Gottschalk C, Peterson D, Armstrong J, Knox K, Roy A Infect Agent Cancer. 2023; 18(1):7.

PMID: 36750846 PMC: 9902840. DOI: 10.1186/s13027-023-00485-z.


Inherited TNFSF9 deficiency causes broad Epstein-Barr virus infection with EBV+ smooth muscle tumors.

Fournier B, Hoshino A, Bruneau J, Bachelet C, Fusaro M, Klifa R J Exp Med. 2022; 219(7).

PMID: 35657354 PMC: 9170382. DOI: 10.1084/jem.20211682.


Loss of GATA4 C-Terminus by p.S335X Mutation Modulates Coronary Artery Vascular Smooth Muscle Cell Phenotype.

Yu T, Chen X, Liu Q, Ma F, Huang H, Zhou L Mediators Inflamm. 2021; 2021:3698386.

PMID: 34545275 PMC: 8449727. DOI: 10.1155/2021/3698386.


Chronic Active Epstein-Barr Virus Infection: The Elucidation of the Pathophysiology and the Development of Therapeutic Methods.

Arai A Microorganisms. 2021; 9(1).

PMID: 33467742 PMC: 7829705. DOI: 10.3390/microorganisms9010180.


References
1.
Kira R, Ihara K, Watanabe K, Kanemitsu S, Ahmed S, Gondo K . Molecular epidemiology of C9 deficiency heterozygotes with an Arg95Stop mutation of the C9 gene in Japan. J Hum Genet. 1999; 44(2):109-11. DOI: 10.1007/s100380050119. View

2.
Cohen J . Epstein-Barr virus infection. N Engl J Med. 2000; 343(7):481-92. DOI: 10.1056/NEJM200008173430707. View

3.
Kanegane H, Nomura K, Miyawaki T, Tosato G . Biological aspects of Epstein-Barr virus (EBV)-infected lymphocytes in chronic active EBV infection and associated malignancies. Crit Rev Oncol Hematol. 2002; 44(3):239-49. DOI: 10.1016/s1040-8428(02)00115-4. View

4.
Katano H, Ali M, Patera A, Catalfamo M, Jaffe E, Kimura H . Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood. 2003; 103(4):1244-52. DOI: 10.1182/blood-2003-06-2171. View

5.
Ehl S, Schwarz K, Enders A, Duffner U, Pannicke U, Kuhr J . A variant of SCID with specific immune responses and predominance of gamma delta T cells. J Clin Invest. 2005; 115(11):3140-8. PMC: 1242191. DOI: 10.1172/JCI25221. View